{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:48:23Z","timestamp":1785509303972,"version":"3.56.0"},"reference-count":42,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,10]]},"DOI":"10.14797\/mdcvj.1760","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:19:05Z","timestamp":1773148745000},"page":"4-13","source":"Crossref","is-referenced-by-count":1,"title":["Mechanistic Insights and Emerging Therapeutic Strategies in Recurrent Pericarditis"],"prefix":"10.14797","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-1635","authenticated-orcid":false,"given":"Mohammad A.","family":"Alqahtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-9402","authenticated-orcid":false,"given":"Tom Kai Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9240-8369","authenticated-orcid":false,"given":"Allan L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"issue":"25","key":"key20260310131903_B1","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2025.05.023","article-title":"2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis: A Report of the American College of Cardiology Solution Set Oversight Committee","volume":"86","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"40","key":"key20260310131903_B2","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC Guidelines for the management of myocarditis and pericarditis","volume":"46","year":"2025","journal-title":"Eur Heart J"},{"issue":"13","key":"key20260310131903_B3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jama.2024.12935","article-title":"Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review","volume":"332","year":"2024","journal-title":"JAMA"},{"issue":"9","key":"key20260310131903_B4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamacardio.2022.2584","article-title":"Advances in Imaging and Targeted Therapies for Recurrent Pericarditis: A Review","volume":"7","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"5","key":"key20260310131903_B5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tcm.2020.04.006","article-title":"The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment","volume":"31","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"key20260310131903_B6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/FJC.0000000000001553","article-title":"Novel Therapeutic Insights Into the Treatment of Pericarditis: Targeting the Innate Immune System","volume":"83","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"issue":"14","key":"key20260310131903_B7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/heartjnl-2019-316481","article-title":"Acute recurrent pericarditis: from pathophysiology towards new treatment strategy","volume":"106","year":"2020","journal-title":"Heart"},{"issue":"8","key":"key20260310131903_B8","first-page":"1103","article-title":"New Developments in the Management of Recurrent Pericarditis","volume":"39","year":"2023","journal-title":"Can J Cardiol"},{"issue":"11","key":"key20260310131903_B9","article-title":"Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center","volume":"11","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"key20260310131903_B10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.autrev.2014.10.005","article-title":"Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis","volume":"14","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"11","key":"key20260310131903_B11","article-title":"Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease","volume":"23","year":"2021","journal-title":"Curr Cardiol Rep"},{"issue":"25","key":"key20260310131903_B12","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1056\/NEJMcp1404070","article-title":"Clinical practice. Acute pericarditis","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"key20260310131903_B13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.amjcard.2021.08.048","article-title":"Pericarditis Recurrence After Initial Uncomplicated Clinical Course","volume":"160","year":"2021","journal-title":"Am J Cardiol"},{"issue":"9","key":"key20260310131903_B14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.echo.2013.06.023","article-title":"American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography","volume":"26","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"issue":"21","key":"key20260310131903_B15","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.jacc.2016.07.785","article-title":"Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key20260310131903_B16","article-title":"Prognostic role of genetic variants in recurrent pericarditis","volume":"439","year":"2025","journal-title":"Int J Cardiol"},{"issue":"14","key":"key20260310131903_B17","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jama.2015.12763","article-title":"Evaluation and Treatment of Pericarditis: A Systematic Review","volume":"314","year":"2015","journal-title":"JAMA"},{"issue":"8","key":"key20260310131903_B18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcmg.2024.04.010","article-title":"Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging","volume":"17","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"key20260310131903_B19","article-title":"Pericardial tissue characterization with quantitative methods in cardiac magnetic resonance in acute or recurrent pericarditis","volume":"439","year":"2025","journal-title":"Int J Cardiol"},{"key":"key20260310131903_B20","article-title":"Added value of cardiac magnetic resonance to clinical diagnostic criteria in the diagnosis of pericarditis: a retrospective cohort study","year":"2025","journal-title":"Heart"},{"issue":"1","key":"key20260310131903_B21","article-title":"Scores for Risk Stratification of Pericarditis","volume":"27","year":"2025","journal-title":"Curr Cardiol Rep"},{"issue":"16","key":"key20260310131903_B22","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"key20260310131903_B23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","year":"2011","journal-title":"Ann Intern Med"},{"issue":"9936","key":"key20260310131903_B24","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","year":"2014","journal-title":"Lancet"},{"issue":"18","key":"key20260310131903_B25","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial","volume":"316","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"key20260310131903_B26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/CRD.0000000000000476","article-title":"Rilonacept and Other Interleukin-1 Inhibitors in the Treatment of Recurrent Pericarditis","volume":"31","year":"2023","journal-title":"Cardiol Rev"},{"issue":"31","key":"key20260310131903_B27","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1093\/eurheartj\/ehab452","article-title":"Anti-interleukin-1 agents for pericarditis: a primer for cardiologists","volume":"43","year":"2022","journal-title":"Eur Heart J"},{"issue":"6","key":"key20260310131903_B28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/FJC.0000000000001435","article-title":"Interleukin-1 Blockers for the Treatment of Recurrent Pericarditis: Pathophysiology, Patient-Reported Outcomes, and Perspectives","volume":"83","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"key20260310131903_B29","first-page":"488","article-title":"Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial","volume":"107","year":"2020","journal-title":"Heart"},{"issue":"1","key":"key20260310131903_B30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"key20260310131903_B31","article-title":"Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis","year":"2025","journal-title":"Heart"},{"issue":"9","key":"key20260310131903_B32","article-title":"IL-1 Pathway Inhibition in Recurrent Pericarditis Management: Real-World Adoption of Corticosteroid Sparing in RESONANCE","volume":"4","year":"2025","journal-title":"JACC Adv"},{"issue":"1","key":"key20260310131903_B33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jacc.2023.04.046","article-title":"Treatment of Idiopathic Recurrent Pericarditis With Goflikicept: Phase II\/III Study Results","volume":"82","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"key20260310131903_B34","article-title":"Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors","volume":"10","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"key20260310131903_B35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jacc.2024.05.048","article-title":"Pericardial Diseases and Best Practices for Pericardiectomy: JACC State-of-the-Art Review","volume":"84","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"key20260310131903_B36","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.mayocp.2012.05.024","article-title":"Pericardiectomy vs medical management in patients with relapsing pericarditis","volume":"87","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"25","key":"key20260310131903_B37","first-page":"07555","article-title":"Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology","volume":"S0735\u20131097","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"key20260310131903_B38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/14656566.2022.2054327","article-title":"Advances in pharmacotherapy for acute and recurrent pericarditis","volume":"23","year":"2022","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"key20260310131903_B39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2019.04.001","article-title":"Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis","volume":"18","year":"2019","journal-title":"Autoimmun Rev"},{"key":"key20260310131903_B40","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2026. CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation (MAVERIC); 2025 Oct 2 [cited 2026 Jan 21]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06708299"},{"key":"key20260310131903_B41","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2026. An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis; 2026 Jan 21 [cited 2026 Jan 28]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06836232"},{"key":"key20260310131903_B42","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2026. Phase 2\/3 Study of KPL-387 in Recurrent Pericarditis; 2026 Jan 21 [cited 2026 Jan 28]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07010159"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:19:10Z","timestamp":1773148750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1760\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,10]]}},"alternative-id":["10.14797\/mdcvj.1760"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1760","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}